Compare Cassava Sciences Inc (FLNA) vs FTAI Aviation Ltd (FTAI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs FTAI Aviation Ltd — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while FTAI Aviation Ltd trades at $225.49 (market cap $23.17B). The key difference: FTAI Aviation Ltd is far larger — about 485.2× Cassava Sciences Inc's market cap, and FTAI Aviation Ltd pays a 0.89% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | FTAI | |
|---|---|---|
Market Cap | $47.75M | $23.17B |
Sector | Health | Industrials |
52-Week High | $4.64 | $310.04 |
52-Week Low | $0.87 | $140.40 |
Enterprise Value | -$34.93M | $26.29B |
Dividend Yield | — | 0.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FTAI Aviation trades at $216.24, down 2.26% for the day, with a bearish technical signal and recent earnings misses. The company reported strong revenue growth to $2.51B in 2025 but faces margin compression, with net income margin declining to 15.94% in 2026. Recent news highlights strategic collaborations and a major power systems order, while analyst consensus remains unanimously bullish with a $341.67 price target.
The outlook is mixed: robust analyst support and growth initiatives in power and MRO segments offer upside, but high valuations (P/E 46.94), earnings misses, and negative operating cash flows pose risks. Investors should weigh long-term growth potential against near-term execution challenges and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About FTAI Aviation Ltd
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →
